Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sandow

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
American Journal of Clinical Oncology|January 1, 1988
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogueJ Waxman, G Williams, J Sandow, et al.
Progress in Clinical and Biological Research|January 1, 1986
Round table discussion of endometriosis and its treatmentV C Buttram, I Brosens, P Magill, et al.
Autophagy|November 8, 2023
Autophagy captures the retromer-TBC1D5 complex to inhibit receptor recyclingJulian M Carosi, Leanne K Hein, Jarrod J Sandow, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
The first clinical use of depot buserelin for advanced prostatic carcinomaJ H Waxman, J Sandow, A Man, et al.
Cell Death & Disease|June 23, 2022
Human RIPK3 C-lobe phosphorylation is essential for necroptotic signalingYanxiang Meng, Christopher R Horne, Andre L Samson, et al.
Journal of Extracellular Vesicles|February 2, 2022
K-29 linked ubiquitination of Arrdc4 regulates its function in extracellular vesicle biogenesisAmmara Usman Farooq, Kelly Gembus, Jarrod J Sandow, et al.
Cell Death and Differentiation|August 20, 2020
Phosphorylation by Aurora B kinase regulates caspase-2 activity and functionYoon Lim, Dylan De Bellis, Jarrod J Sandow, et al.
The Prostate|January 1, 1983
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgensF Labrie, A Dupont, A Belanger, et al.
Urological Research|January 1, 1989
Pharmacokinetics and endocrine effects of the LHR analogue buserelin after subcutaneous implantation of a slow release preparation in prostatic cancer patientsJ H Blom, W H Hirdes, F H Schröder, et al.
The Journal of Biological Chemistry|October 29, 2022
Inflammasome sensor NLRP1 disease variant M1184V promotes autoproteolysis and DPP9 complex formation by stabilizing the FIIND domainJonas Moecking, Pawat Laohamonthonkul, Kubilay Meşe, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
American Journal of Clinical Oncology|January 1, 1988
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogueJ Waxman, G Williams, J Sandow, et al.
Progress in Clinical and Biological Research|January 1, 1986
Round table discussion of endometriosis and its treatmentV C Buttram, I Brosens, P Magill, et al.
Autophagy|November 8, 2023
Autophagy captures the retromer-TBC1D5 complex to inhibit receptor recyclingJulian M Carosi, Leanne K Hein, Jarrod J Sandow, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
The first clinical use of depot buserelin for advanced prostatic carcinomaJ H Waxman, J Sandow, A Man, et al.
Cell Death & Disease|June 23, 2022
Human RIPK3 C-lobe phosphorylation is essential for necroptotic signalingYanxiang Meng, Christopher R Horne, Andre L Samson, et al.
Journal of Extracellular Vesicles|February 2, 2022
K-29 linked ubiquitination of Arrdc4 regulates its function in extracellular vesicle biogenesisAmmara Usman Farooq, Kelly Gembus, Jarrod J Sandow, et al.
Cell Death and Differentiation|August 20, 2020
Phosphorylation by Aurora B kinase regulates caspase-2 activity and functionYoon Lim, Dylan De Bellis, Jarrod J Sandow, et al.
The Prostate|January 1, 1983
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgensF Labrie, A Dupont, A Belanger, et al.
Urological Research|January 1, 1989
Pharmacokinetics and endocrine effects of the LHR analogue buserelin after subcutaneous implantation of a slow release preparation in prostatic cancer patientsJ H Blom, W H Hirdes, F H Schröder, et al.
The Journal of Biological Chemistry|October 29, 2022
Inflammasome sensor NLRP1 disease variant M1184V promotes autoproteolysis and DPP9 complex formation by stabilizing the FIIND domainJonas Moecking, Pawat Laohamonthonkul, Kubilay Meşe, et al.
Pageof 19